| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0004867415571168 |
| P8608 | Fatcat ID | release_qhvsnmkrm5a5dbxvre2d4uzr2a |
| P698 | PubMed publication ID | 25690743 |
| P5875 | ResearchGate publication ID | 271645550 |
| P50 | author | Simon M. Rice | Q47816686 |
| P2093 | author name string | Sung-Wan Kim | |
| Martha Feucht | |||
| Thomas J Whitford | |||
| G Paul Amminger | |||
| Robert K McNamara | |||
| Franz Benninger | |||
| Suzie Lavoie | |||
| Claudia M Klier | |||
| Miriam R Schäfer | |||
| P2860 | cites work | Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study | Q24615766 |
| Electroencephalographic signatures of attentional and cognitive default modes in spontaneous brain activity fluctuations at rest | Q24685697 | ||
| Monitoring and care of young people at incipient risk of psychosis | Q28288354 | ||
| New vistas for α-frequency band oscillations | Q30052035 | ||
| Endogenous brain oscillations and related networks detected by surface EEG-combined fMRI. | Q31154778 | ||
| Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia | Q33179595 | ||
| Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group | Q34167452 | ||
| Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects | Q34465150 | ||
| Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up | Q34596645 | ||
| Evidence-based medicine and electrophysiology in schizophrenia | Q34608986 | ||
| Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial | Q34616402 | ||
| The role of polyunsaturated fatty acids in restoring the aging neuronal membrane | Q34977011 | ||
| The status of spectral EEG abnormality as a diagnostic test for schizophrenia | Q36528917 | ||
| Omega-3 fatty acids and monoamine neurotransmission | Q36590185 | ||
| Docosahexaenoic acid in neural signaling systems | Q36688758 | ||
| (N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders. | Q36830364 | ||
| Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression | Q37267204 | ||
| Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review | Q37472526 | ||
| Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis | Q38052196 | ||
| Resting state electroencephalographic correlates with red cell long-chain fatty acids, memory performance and age in adolescent boys with attention deficit hyperactivity disorder | Q38380052 | ||
| The membrane hypothesis of schizophrenia | Q40582385 | ||
| Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation | Q41185182 | ||
| Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study | Q43088456 | ||
| Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. | Q43772382 | ||
| A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms | Q43832862 | ||
| Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia | Q44118975 | ||
| EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis | Q45186008 | ||
| Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease | Q46651514 | ||
| Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study | Q46804734 | ||
| A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia | Q48376084 | ||
| Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis | Q48558075 | ||
| Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis. | Q50719449 | ||
| Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals | Q59210038 | ||
| P433 | issue | 1 | |
| P921 | main subject | psychosis | Q170082 |
| electroencephalography | Q179965 | ||
| P304 | page(s) | 56-63 | |
| P577 | publication date | 2015-02-17 | |
| P1433 | published in | Australian and New Zealand Journal of Psychiatry | Q4824838 |
| P1476 | title | Correlates of electroencephalographic resting states and erythrocyte membrane docosahexaenoic and eicosapentaenoic acid levels in individuals at ultra-high risk of psychosis | |
| P478 | volume | 50 |
| Q41547279 | High predictive values of RBC membrane-based diagnostics by biophotonics in an integrated approach for Autism Spectrum Disorders |
| Q64897230 | N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders |
| Q37307208 | Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers |
Search more.